The present invention relates to the development of a new type of antimicrobial molecule (AbTids) which is modular in nature, adaptable against a multitude of pathogens, combining the best therapeutic properties of antibodies (Ab-) and catiomc antimicrobial peptides (-Tids) to target microbes, particularly against d...

The present invention describes a method of controlling parasitic helminths by probiotic food mediated RNAi knockdown of essential helminth genes, which are responsible for locomotion, nutrient assimilation, attachment and neuromuscular function. For this purpose, RNAi vectors capable of producing parasite target sp...

The present invention relates to a novel antibody fragment based antimicrobial conjugate selectively targeting Pseudomonas spp., preferably Pseudomonas aeruginosa, comprising of at least one antimicrobial peptide at one end of the conjugate preferably human Histatin-5; at least one antibody fragment at the other end...

The present invention provides a novel antibody fragment based antifungal conjugate selectively targeting Candida spp. comprising of at least one antimicrobial peptide at one end of the conjugate, more particularly, human Histatin-5; an antibody fragment at the other end of the conjugate, specific against Candida sp...

The present disclosure describes multi-well plates comprising a frame made of a first material having an array of a plurality of holes arranged in a columnar pattern on the top surface and an array of segmented breaking features arranged in a linear columnar pattern which alternates with the columnar pattern of the ...

“A COMPOSITION EFFECTIVE AGAINST BETA-LACTAM ANTIBIOTIC-RESISTANT PSEUDOMONAS AERUGINOSA” ABSTRACT The present invention provides a synergistic composition effecting against ß-lactam antibiotic-resistant Pseudomonas aeruginosa comprising at least one antibiotic against Pseudomonas aeruginosa, and at least one anti...